You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Össur - Executes on its Growth’27 strategy with the acquisition of FIOR & GENTZ
Today, Össur announced an M&A transaction, as the company has acquired FIOR & GENTZ, a leading maker of lower limb neuro orthotic components. This is clearly in line with its Growth'27 strategy that includes M&A on top of organic growth and as a priority for capital allocation.
For more details about the transaction, read here: https://view.news.eu.nasdaq.com/view?id=bf02fffe8f205c68bb226b23d231cf297&lang=en&src=listed
Together with Össur's CEO, we went through some of the transaction details, what they are buying, the strategic fit, and how this transaction will create value for shareholders.
Össur is a leading global provider of innovative mobility solutions in the medical technology space. Össur improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying Patient Care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Össur has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.
Disclaimer: HC Andersen Capital receives payment from Össur for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 17:30, 16 January 2024.